169 related articles for article (PubMed ID: 38041073)
1. Acute pancreatitis in intraductal papillary mucinous neoplasm: a single-center retrospective cohort study with systematic review and meta-analysis.
Xu JH; Ni CY; Zhuang YY; Li L; Lin Y; Xia ZS; Wu WR; Chen QK; Zhong W
BMC Gastroenterol; 2023 Dec; 23(1):424. PubMed ID: 38041073
[TBL] [Abstract][Full Text] [Related]
2. [Diagnostic efficacy for predicting intraductal papillary mucinous neoplasms of the pancreas with high grade dysplasia or invasive carcinoma based on the surgery indications in different guidelines].
Li B; Guo SW; Shi XH; Shen S; Zhang GX; Gao SZ; Pan YQ; Xu XF; Jin G
Zhonghua Wai Ke Za Zhi; 2021 May; 59(5):359-365. PubMed ID: 33915626
[No Abstract] [Full Text] [Related]
3. Acute pancreatitis in intraductal papillary mucinous neoplasms: A common predictor of malignant intestinal subtype.
Morales-Oyarvide V; Mino-Kenudson M; Ferrone CR; Gonzalez-Gonzalez LA; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
Surgery; 2015 Nov; 158(5):1219-25. PubMed ID: 26077509
[TBL] [Abstract][Full Text] [Related]
4. MUC2 expression and prevalence of high-grade dysplasia and invasive carcinoma in mixed-type intraductal papillary mucinous neoplasm of the pancreas.
Masuda A; Arisaka Y; Hara S; Matsumoto I; Takenaka M; Sakai A; Shiomi H; Matsuki N; Sugimoto M; Fujita T; Hayakumo T; Ku Y; Ogino S; Azuma T; Kutsumi H
Pancreatology; 2013; 13(6):583-8. PubMed ID: 24280573
[TBL] [Abstract][Full Text] [Related]
5. Diabetes mellitus in intraductal papillary mucinous neoplasm of the pancreas is associated with high-grade dysplasia and invasive carcinoma.
Morales-Oyarvide V; Mino-Kenudson M; Ferrone CR; Sahani DV; Pergolini I; Negreros-Osuna AA; Warshaw AL; Lillemoe KD; Fernández-Del Castillo C
Pancreatology; 2017; 17(6):920-926. PubMed ID: 28890154
[TBL] [Abstract][Full Text] [Related]
6. Dilated papilla with mucin extrusion is a potential predictor of acute pancreatitis associated with intraductal papillary mucinous neoplasms of pancreas.
Hata T; Sakata N; Okada T; Aoki T; Motoi F; Katayose Y; Egawa S; Unno M
Pancreatology; 2013; 13(6):615-20. PubMed ID: 24280579
[TBL] [Abstract][Full Text] [Related]
7. Clinical characteristics of intraductal papillary mucinous neoplasm manifesting as acute pancreatitis or acute recurrent pancreatitis.
Jang JW; Kim MH; Jeong SU; Kim J; Park DH; Lee SS; Seo DW; Lee SK; Kim JH
J Gastroenterol Hepatol; 2013 Apr; 28(4):731-8. PubMed ID: 23301513
[TBL] [Abstract][Full Text] [Related]
8. Intraductal papillary mucinous neoplasm and acute pancreatitis.
Venkatesh PG; Navaneethan U; Vege SS
J Clin Gastroenterol; 2011 Oct; 45(9):755-8. PubMed ID: 21602701
[TBL] [Abstract][Full Text] [Related]
9. Acute pancreatitis in intraductal papillary mucinous neoplasms correlates with pancreatic volume and epithelial subtypes.
Tanaka T; Masuda A; Sofue K; Toyama H; Shiomi H; Sakai A; Kobayashi T; Tanaka S; Nakano R; Yamada Y; Ashina S; Tsujimae M; Yamakawa K; Abe S; Gonda M; Masuda S; Inomata N; Uemura H; Kohashi S; Nagao K; Kanzawa M; Itoh T; Fukumoto T; Kodama Y
Pancreatology; 2021 Jan; 21(1):138-143. PubMed ID: 33328127
[TBL] [Abstract][Full Text] [Related]
10. Importance of each high-risk stigmata and worrisome features as a predictor of high-grade dysplasia in intraductal papillary mucinous neoplasms of the pancreas.
Izumo W; Higuchi R; Furukawa T; Yazawa T; Uemura S; Shiihara M; Yamamoto M
Pancreatology; 2020 Jul; 20(5):895-901. PubMed ID: 32624417
[TBL] [Abstract][Full Text] [Related]
11. Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram.
Correa-Gallego C; Do R; Lafemina J; Gonen M; D'Angelica MI; DeMatteo RP; Fong Y; Kingham TP; Brennan MF; Jarnagin WR; Allen PJ
Ann Surg Oncol; 2013 Dec; 20(13):4348-55. PubMed ID: 24046103
[TBL] [Abstract][Full Text] [Related]
12. Intraductal papillary mucinous neoplasm of the pancreas and IgG4-related disease: a coincidental association.
Tabata T; Kamisawa T; Hara S; Kuruma S; Chiba K; Kuwata G; Fujiwara T; Egashira H; Koizumi S; Endo Y; Koizumi K; Fujiwara J; Arakawa T; Momma K; Horiguchi S; Hishima T; Kurata M; Honda G; Kloppel G
Pancreatology; 2013; 13(4):379-83. PubMed ID: 23890136
[TBL] [Abstract][Full Text] [Related]
13. Association between the Risk Factors for Pancreatic Ductal Adenocarcinoma and Those for Malignant Intraductal Papillary Mucinous Neoplasm.
Kamata K; Takenaka M; Nakai A; Omoto S; Miyata T; Minaga K; Matsuda T; Yamao K; Imai H; Chiba Y; Sakurai T; Watanabe T; Nishida N; Chikugo T; Matsumoto I; Takeyama Y; Kudo M
Oncology; 2017; 93 Suppl 1():102-106. PubMed ID: 29258117
[TBL] [Abstract][Full Text] [Related]
14. Segmental Versus Diffuse Main Duct Intraductal Papillary Mucinous Neoplasm: Examination of Main Pancreatic Duct Morphology and Implications for Malignancy Risk and Extent of Surgical Resection.
Ecker BL; Dickinson SM; Saadat LV; Tao AJ; Pulvirenti A; Balachandran VP; D'Angelica MI; Drebin JA; Kingham TP; Jarnagin WR; Wei AC; Gonen M; Soares KC
Ann Surg; 2023 Jul; 278(1):110-117. PubMed ID: 35950775
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors for the Metachronous Development of High-risk Lesions in the Remnant Pancreas After Partial Pancreatectomy for Intraductal Papillary Mucinous Neoplasm.
Miyasaka Y; Ohtsuka T; Tamura K; Mori Y; Shindo K; Yamada D; Takahata S; Ishigami K; Ito T; Tokunaga S; Oda Y; Mizumoto K; Nakamura M; Tanaka M
Ann Surg; 2016 Jun; 263(6):1180-7. PubMed ID: 26334637
[TBL] [Abstract][Full Text] [Related]
16. Malignant potential and specific characteristics of pure main duct type intraductal papillary mucinous neoplasm.
Fujita Y; Hirono S; Kawai M; Okada KI; Miyazawa M; Kitahata Y; Ueno M; Hayami S; Kobayashi R; Yanagisawa A; Yamaue H
Eur J Surg Oncol; 2022 May; 48(5):1054-1061. PubMed ID: 34933794
[TBL] [Abstract][Full Text] [Related]
17. Utility of the 2006 Sendai and 2012 Fukuoka guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas: A single-center experience with 138 surgically treated patients.
Hsiao CY; Yang CY; Wu JM; Kuo TC; Tien YW
Medicine (Baltimore); 2016 Sep; 95(38):e4922. PubMed ID: 27661043
[TBL] [Abstract][Full Text] [Related]
18. Imaging Features for Predicting High-Grade Dysplasia or Malignancy in Branch Duct Type Intraductal Papillary Mucinous Neoplasm of the Pancreas: A Systematic Review and Meta-Analysis.
Zhao W; Liu S; Cong L; Zhao Y
Ann Surg Oncol; 2022 Feb; 29(2):1297-1312. PubMed ID: 34554343
[TBL] [Abstract][Full Text] [Related]
19. Fate of Patients With Intraductal Papillary Mucinous Neoplasms of Pancreas After Resection According to the Pathology and Margin Status: Continuously Increasing Risk of Recurrence Even After Curative Resection Suggesting Necessity of Lifetime Surveillance.
Kim HS; Han Y; Kang JS; Choi YJ; Byun Y; Kim H; Lee KB; Kim H; Kwon W; Jang JY
Ann Surg; 2022 Oct; 276(4):e231-e238. PubMed ID: 32941274
[TBL] [Abstract][Full Text] [Related]
20. Assessment of a Revised Management Strategy for Patients With Intraductal Papillary Mucinous Neoplasms Involving the Main Pancreatic Duct.
Sugimoto M; Elliott IA; Nguyen AH; Kim S; Muthusamy VR; Watson R; Hines OJ; Dawson DW; Reber HA; Donahue TR
JAMA Surg; 2017 Jan; 152(1):e163349. PubMed ID: 27829085
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
